ABLE Financial Group LLC Buys 2,692 Shares of HealthEquity, Inc. (NASDAQ:HQY)

ABLE Financial Group LLC increased its position in HealthEquity, Inc. (NASDAQ:HQY) by 15.5% during the 3rd quarter, Holdings Channel reports. The firm owned 20,016 shares of the company’s stock after acquiring an additional 2,692 shares during the quarter. ABLE Financial Group LLC’s holdings in HealthEquity were worth $1,638,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Norden Group LLC purchased a new position in HealthEquity during the 1st quarter valued at about $391,000. BNP Paribas Financial Markets increased its holdings in HealthEquity by 15.3% during the first quarter. BNP Paribas Financial Markets now owns 49,286 shares of the company’s stock valued at $4,023,000 after buying an additional 6,536 shares during the period. Janney Montgomery Scott LLC raised its stake in HealthEquity by 27.4% in the first quarter. Janney Montgomery Scott LLC now owns 3,970 shares of the company’s stock worth $324,000 after buying an additional 855 shares in the last quarter. Texas Permanent School Fund Corp lifted its holdings in HealthEquity by 1.5% during the first quarter. Texas Permanent School Fund Corp now owns 75,092 shares of the company’s stock worth $6,130,000 after buying an additional 1,121 shares during the period. Finally, Lisanti Capital Growth LLC bought a new stake in HealthEquity during the 1st quarter valued at $4,701,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently commented on HQY. JMP Securities reissued a “market outperform” rating and issued a $105.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. Royal Bank of Canada reiterated an “outperform” rating and issued a $92.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. Barrington Research restated an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a report on Friday, September 20th. Bank of America decreased their target price on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and an average target price of $103.83.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the transaction, the director now owns 54,719 shares in the company, valued at approximately $4,540,582.62. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the transaction, the director now directly owns 54,719 shares of the company’s stock, valued at $4,540,582.62. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Frank Corvino sold 1,247 shares of the business’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the transaction, the director now owns 4,823 shares of the company’s stock, valued at approximately $387,093.98. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by corporate insiders.

HealthEquity Stock Performance

Shares of HQY stock traded down $0.11 during mid-day trading on Friday, reaching $97.09. The stock had a trading volume of 87,078 shares, compared to its average volume of 613,340. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 1-year low of $62.10 and a 1-year high of $99.57. The firm has a market cap of $8.48 billion, a price-to-earnings ratio of 81.00, a PEG ratio of 1.36 and a beta of 0.52. The business’s fifty day moving average is $82.77 and its 200-day moving average is $80.31.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. The company had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. On average, research analysts forecast that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.